DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: PET Imaging of Fatty Acid Amide Hydrolase with [18F]DOPP in Nonhuman Primates

Abstract

Here, the fatty acid amide hydrolase (FAAH) regulates endocannabinoid signaling. [11C]CURB, an irreversibly binding FAAH inhibitor, has been developed for clinical research imaging with PET. However, no fluorine-18 labeled radiotracer for FAAH has yet advanced to human studies. [18F]DOPP ([18F]3-(4,5-dihydrooxazol-2-yl)phenyl (5-fluoropentyl)carbamate) has been identified as a promising 18F-labeled analogue based on rodent studies. The goal of this work is to evaluate [18F]DOPP in nonhuman primates to support its clinical translation. High specific activity [18F]DOPP (5–6 Ci·μmol–1) was administered intravenously (iv) to three baboons (2M/1F, 3–4 years old). The distribution and pharmacokinetics were quantified following a 2 h dynamic imaging session using a simultaneous PET/MR scanner. Pretreatment with the FAAH-selective inhibitor, URB597, was carried out at 200 or 300 μg/kg iv, 10 min prior to [18F]DOPP administration. Rapid arterial blood sampling for the first 3 min was followed by interval sampling with metabolite analysis to provide a parent radiotracer plasma input function that indicated ~95% baseline metabolism at 60 min and a reduced rate of metabolism after pretreatment with URB597. Regional distribution data were analyzed with 1-, 2-, and 3-tissue compartment models (TCMs), with and without irreversible trapping since [18F]DOPP covalently links to the active site of FAAH. Consistent with previousmore » findings for [11C]CURB, the 2TCM with irreversible binding was found to provide the best fit for modeling the data in all regions. The composite parameter λk3 was therefore used to evaluate whole brain (WB) and regional binding of [18F]DOPP. Pretreatment studies showed inhibition of λk3 across all brain regions (WB baseline: 0.112 mL/cm3/min; 300 μg/kg URB597: 0.058 mL/cm3/min), suggesting that [18F]DOPP binding is specific for FAAH, consistent with previous rodent data.« less

Authors:
 [1];  [2];  [1];  [3];  [1];  [2];  [1]
  1. Massachusetts General Hospital, Charlestown, MA (United States); Harvard Medical School, Boston, MA (United States)
  2. Harvard Medical School, Boston, MA (United States); Massachusetts General Hospital, Charlestown, MA (United States)
  3. Univ. of Toronto, Toronto, ON (Canada)
Publication Date:
Research Org.:
Massachusetts General Hospital, Charlestown, MA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1440558
Grant/Contract Number:  
SC0008430
Resource Type:
Accepted Manuscript
Journal Name:
Molecular Pharmaceutics
Additional Journal Information:
Journal Volume: 11; Journal Issue: 11; Journal ID: ISSN 1543-8384
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY; FAAH; fatty acid amide hydrolase; kinetic modeling; PET; positron emission tomography; [18F]DOPP

Citation Formats

Rotstein, Benjamin H., Wey, Hsiao -Ying, Shoup, Timothy M., Wilson, Alan A., Liang, Steven H., Hooker, Jacob M., and Vasdev, Neil. PET Imaging of Fatty Acid Amide Hydrolase with [18F]DOPP in Nonhuman Primates. United States: N. p., 2014. Web. doi:10.1021/mp500316h.
Rotstein, Benjamin H., Wey, Hsiao -Ying, Shoup, Timothy M., Wilson, Alan A., Liang, Steven H., Hooker, Jacob M., & Vasdev, Neil. PET Imaging of Fatty Acid Amide Hydrolase with [18F]DOPP in Nonhuman Primates. United States. https://doi.org/10.1021/mp500316h
Rotstein, Benjamin H., Wey, Hsiao -Ying, Shoup, Timothy M., Wilson, Alan A., Liang, Steven H., Hooker, Jacob M., and Vasdev, Neil. Tue . "PET Imaging of Fatty Acid Amide Hydrolase with [18F]DOPP in Nonhuman Primates". United States. https://doi.org/10.1021/mp500316h. https://www.osti.gov/servlets/purl/1440558.
@article{osti_1440558,
title = {PET Imaging of Fatty Acid Amide Hydrolase with [18F]DOPP in Nonhuman Primates},
author = {Rotstein, Benjamin H. and Wey, Hsiao -Ying and Shoup, Timothy M. and Wilson, Alan A. and Liang, Steven H. and Hooker, Jacob M. and Vasdev, Neil},
abstractNote = {Here, the fatty acid amide hydrolase (FAAH) regulates endocannabinoid signaling. [11C]CURB, an irreversibly binding FAAH inhibitor, has been developed for clinical research imaging with PET. However, no fluorine-18 labeled radiotracer for FAAH has yet advanced to human studies. [18F]DOPP ([18F]3-(4,5-dihydrooxazol-2-yl)phenyl (5-fluoropentyl)carbamate) has been identified as a promising 18F-labeled analogue based on rodent studies. The goal of this work is to evaluate [18F]DOPP in nonhuman primates to support its clinical translation. High specific activity [18F]DOPP (5–6 Ci·μmol–1) was administered intravenously (iv) to three baboons (2M/1F, 3–4 years old). The distribution and pharmacokinetics were quantified following a 2 h dynamic imaging session using a simultaneous PET/MR scanner. Pretreatment with the FAAH-selective inhibitor, URB597, was carried out at 200 or 300 μg/kg iv, 10 min prior to [18F]DOPP administration. Rapid arterial blood sampling for the first 3 min was followed by interval sampling with metabolite analysis to provide a parent radiotracer plasma input function that indicated ~95% baseline metabolism at 60 min and a reduced rate of metabolism after pretreatment with URB597. Regional distribution data were analyzed with 1-, 2-, and 3-tissue compartment models (TCMs), with and without irreversible trapping since [18F]DOPP covalently links to the active site of FAAH. Consistent with previous findings for [11C]CURB, the 2TCM with irreversible binding was found to provide the best fit for modeling the data in all regions. The composite parameter λk3 was therefore used to evaluate whole brain (WB) and regional binding of [18F]DOPP. Pretreatment studies showed inhibition of λk3 across all brain regions (WB baseline: 0.112 mL/cm3/min; 300 μg/kg URB597: 0.058 mL/cm3/min), suggesting that [18F]DOPP binding is specific for FAAH, consistent with previous rodent data.},
doi = {10.1021/mp500316h},
journal = {Molecular Pharmaceutics},
number = 11,
volume = 11,
place = {United States},
year = {Tue Jul 08 00:00:00 EDT 2014},
month = {Tue Jul 08 00:00:00 EDT 2014}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 15 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

The molecular logic of endocannabinoid signalling
journal, November 2003

  • Piomelli, Daniele
  • Nature Reviews Neuroscience, Vol. 4, Issue 11
  • DOI: 10.1038/nrn1247

Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System
journal, May 2008

  • Ahn, Kay; McKinney, Michele K.; Cravatt, Benjamin F.
  • Chemical Reviews, Vol. 108, Issue 5
  • DOI: 10.1021/cr0782067

Supply and demand for endocannabinoids
journal, June 2011


The cannabinoid system and its pharmacological manipulation ? a review, with emphasis upon the uptake and hydrolysis of anandamide
journal, December 2006


Anandamide uptake explained?
journal, April 2012


Targeting the endocannabinoid system: to enhance or reduce?
journal, May 2008

  • Di Marzo, Vincenzo
  • Nature Reviews Drug Discovery, Vol. 7, Issue 5
  • DOI: 10.1038/nrd2553

Chemical Probes of Endocannabinoid Metabolism
journal, February 2013

  • Blankman, Jacqueline L.; Cravatt, Benjamin F.
  • Pharmacological Reviews, Vol. 65, Issue 2
  • DOI: 10.1124/pr.112.006387

Modulation of anxiety through blockade of anandamide hydrolysis
journal, December 2002

  • Kathuria, Satish; Gaetani, Silvana; Fegley, Darren
  • Nature Medicine, Vol. 9, Issue 1
  • DOI: 10.1038/nm803

Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor
journal, November 2010

  • Johnson, Douglas S.; Stiff, Cory; Lazerwith, Scott E.
  • ACS Medicinal Chemistry Letters, Vol. 2, Issue 2
  • DOI: 10.1021/ml100190t

Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
journal, April 2011

  • Ahn, Kay; Smith, Sarah E.; Liimatta, Marya B.
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 338, Issue 1
  • DOI: 10.1124/jpet.111.180257

Synthesis, In Vitro and In Vivo Evaluation, and Radiolabeling of Aryl Anandamide Analogues as Candidate Radioligands for In Vivo Imaging of Fatty Acid Amide Hydrolase in the Brain
journal, August 2009

  • wyffels, Leonie; Muccioli, Giulio G.; De Bruyne, Sylvie
  • Journal of Medicinal Chemistry, Vol. 52, Issue 15
  • DOI: 10.1021/jm900324e

Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase
journal, August 2013


The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH)
journal, October 2012


Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase
journal, April 2013

  • Liu, Ping; Hamill, Terence G.; Chioda, Marc
  • ACS Medicinal Chemistry Letters, Vol. 4, Issue 6
  • DOI: 10.1021/ml4000996

PET imaging of fatty acid amide hydrolase in the brain: synthesis and biological evaluation of an 11C-labelled URB597 analogue
journal, July 2010


[11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography
journal, February 2011


Radiosynthesis and Evaluation of [ 11 C- Carbonyl ]-Labeled Carbamates as Fatty Acid Amide Hydrolase Radiotracers for Positron Emission Tomography
journal, December 2012

  • Wilson, Alan A.; Hicks, Justin W.; Sadovski, Oleg
  • Journal of Medicinal Chemistry, Vol. 56, Issue 1
  • DOI: 10.1021/jm301492y

11CO2 fixation: a renaissance in PET radiochemistry
journal, January 2013

  • Rotstein, Benjamin H.; Liang, Steven H.; Holland, Jason P.
  • Chemical Communications, Vol. 49, Issue 50
  • DOI: 10.1039/c3cc42236d

Mapping Human Brain Fatty Acid Amide Hydrolase Activity with PET
journal, December 2012

  • Rusjan, Pablo M.; Wilson, Alan A.; Mizrahi, Romina
  • Journal of Cerebral Blood Flow & Metabolism, Vol. 33, Issue 3
  • DOI: 10.1038/jcbfm.2012.180

Mechanism of Carbamate Inactivation of FAAH: Implications for the Design of Covalent Inhibitors and In Vivo Functional Probes for Enzymes
journal, November 2005


The fatty acid amide hydrolase (FAAH)
journal, November 2000


Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study
journal, April 2002


Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolase
journal, July 2013

  • Sadovski, Oleg; Hicks, Justin W.; Parkes, Jun
  • Bioorganic & Medicinal Chemistry, Vol. 21, Issue 14
  • DOI: 10.1016/j.bmc.2013.04.077

Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets
journal, March 2007


Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma
journal, November 2005


Synthesis and polymerization reactions of cyclic imino ethers. I. Ring-opening homopolyaddition of AB-type hydroxyphenyl-substituted 2-oxazolines
journal, January 2005

  • Lustoň, Jozef; Kronek, Juraj; Böhme, Frank
  • Journal of Polymer Science Part A: Polymer Chemistry, Vol. 44, Issue 1
  • DOI: 10.1002/pola.21159

Template Images for Nonhuman Primate Neuroimaging: 1. Baboon
journal, September 2001

  • Black, Kevin J.; Snyder, Abraham Z.; Koller, Jonathan M.
  • NeuroImage, Vol. 14, Issue 3
  • DOI: 10.1006/nimg.2001.0752

Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity
journal, June 2004

  • Lichtman, Aron H.; Leung, Donmienne; Shelton, Christopher C.
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 311, Issue 2
  • DOI: 10.1124/jpet.104.069401

The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys
journal, August 2011


The Assay of Enzyme Activity by Positron Emission Tomography
book, January 2012

  • Cumming, Paul; Vasdev, Neil
  • Molecular Imaging in the Clinical Neurosciences
  • DOI: 10.1007/7657_2012_53

Anaesthesia for positron emission tomography scanning of animal brains
journal, January 2013

  • Alstrup, Aage Kristian Olsen; Smith, Donald F.
  • Laboratory Animals, Vol. 47, Issue 1
  • DOI: 10.1258/la.2012.011173

Template Images for Nonhuman Primate Neuroimaging: 1. Baboon
journal, September 2001

  • Black, Kevin J.; Snyder, Abraham Z.; Koller, Jonathan M.
  • NeuroImage, Vol. 14, Issue 3
  • DOI: 10.1006/nimg.2001.0752

Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma
journal, November 2005


Mechanism of Carbamate Inactivation of FAAH: Implications for the Design of Covalent Inhibitors and In Vivo Functional Probes for Enzymes
journal, November 2005


Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets
journal, March 2007


PET imaging of fatty acid amide hydrolase in the brain: synthesis and biological evaluation of an 11C-labelled URB597 analogue
journal, July 2010


[11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography
journal, February 2011


Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase
journal, August 2013


Inhibitors of endocannabinoid breakdown for pain: Not so FA(AH)cile, after all
journal, September 2012


Supply and demand for endocannabinoids
journal, June 2011


Anandamide uptake explained?
journal, April 2012


Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System
journal, May 2008

  • Ahn, Kay; McKinney, Michele K.; Cravatt, Benjamin F.
  • Chemical Reviews, Vol. 108, Issue 5
  • DOI: 10.1021/cr0782067

Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor
journal, November 2010

  • Johnson, Douglas S.; Stiff, Cory; Lazerwith, Scott E.
  • ACS Medicinal Chemistry Letters, Vol. 2, Issue 2
  • DOI: 10.1021/ml100190t

Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase
journal, April 2013

  • Liu, Ping; Hamill, Terence G.; Chioda, Marc
  • ACS Medicinal Chemistry Letters, Vol. 4, Issue 6
  • DOI: 10.1021/ml4000996

Mapping Human Brain Fatty Acid Amide Hydrolase Activity with PET
journal, December 2012

  • Rusjan, Pablo M.; Wilson, Alan A.; Mizrahi, Romina
  • Journal of Cerebral Blood Flow & Metabolism, Vol. 33, Issue 3
  • DOI: 10.1038/jcbfm.2012.180

Modulation of anxiety through blockade of anandamide hydrolysis
journal, December 2002

  • Kathuria, Satish; Gaetani, Silvana; Fegley, Darren
  • Nature Medicine, Vol. 9, Issue 1
  • DOI: 10.1038/nm803

The molecular logic of endocannabinoid signalling
journal, November 2003

  • Piomelli, Daniele
  • Nature Reviews Neuroscience, Vol. 4, Issue 11
  • DOI: 10.1038/nrn1247

The cannabinoid system and its pharmacological manipulation ? a review, with emphasis upon the uptake and hydrolysis of anandamide
journal, December 2006


The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys
journal, August 2011


Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity
journal, June 2004

  • Lichtman, Aron H.; Leung, Donmienne; Shelton, Christopher C.
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 311, Issue 2
  • DOI: 10.1124/jpet.104.069401

Anaesthesia for positron emission tomography scanning of animal brains
journal, January 2013

  • Alstrup, Aage Kristian Olsen; Smith, Donald F.
  • Laboratory Animals, Vol. 47, Issue 1
  • DOI: 10.1258/la.2012.011173

Works referencing / citing this record:

A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety
journal, June 2016

  • Sawatzky, Edgar; Al-Momani, Ehab; Kobayashi, Ryohei
  • ChemMedChem, Vol. 11, Issue 14
  • DOI: 10.1002/cmdc.201600223

11 CO bonds made easily for positron emission tomography radiopharmaceuticals
journal, January 2016

  • Rotstein, Benjamin H.; Liang, Steven H.; Placzek, Michael S.
  • Chemical Society Reviews, Vol. 45, Issue 17
  • DOI: 10.1039/c6cs00310a

Fluorine-18 labelled building blocks for PET tracer synthesis
journal, January 2017

  • van der Born, Dion; Pees, Anna; Poot, Alex J.
  • Chem. Soc. Rev., Vol. 46, Issue 15
  • DOI: 10.1039/c6cs00492j

Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT
journal, January 2017